SP100B is a repressor of gene expression.

Area of Science:

• Cell Biology
• Molecular Biology
• Immunology

Background:

• Mammalian cell nuclei contain specific protein localization sites known as PML nuclear bodies (PML NBs) or nuclear domain 10s (ND10s).
• PML NBs are characterized by the presence of promyelocytic leukemia (PML) protein and SP100 autoantigen.
• Evidence suggests PML NBs may suppress viral infections by repressing viral gene expression, as indicated by their response to interferon and viral protein interactions.

Purpose of the Study:

• To investigate whether components of PML NBs function as gene expression repressors.
• To test the hypothesis that specific isoforms of PML or SP100 proteins possess transcriptional repressor activity.

Main Methods:

• Transfected reporter genes were used to assess the effect of different PML and SP100 isoforms on gene expression.
• Reporter gene expression was analyzed under conditions of elevated expression, including stimulation by a viral transactivator or trichostatin A.
• The role of the SP100B DNA binding domain in repression was investigated.

Main Results:

• PML-I, PML-VI, and SP100A isoforms did not exhibit significant repression of reporter gene expression.
• SP100B demonstrated repressive activity on reporter gene expression, particularly when expression was enhanced by viral transactivators or trichostatin A.
• The DNA binding domain of SP100B was essential for its repressive function, while it did not affect DNA methylation or topology.

Conclusions:

• The findings support the hypothesis that SP100B acts as a transcriptional repressor.
• SP100B's repressive activity suggests its role as a component of the innate immune system.
• SP100B may contribute to host defense by repressing the expression of foreign or viral DNA.